Each year 14,000 Queenslanders are newly diagnosed with cancer. The Mater Adult Hospital and Mater Private Hospital provide exceptional care for 3,000 of these newly diagnosed patients annually.
Caring for people with cancer has been a focus for the Mater Hospitals since Queensland’s first X-ray therapy machine was installed in the Mater Public Hospital in 1928.
Today, the Mater provides cancer care for people of all ages, from babies to the elderly, and also conducts vital research into new ways to diagnose, treat, and where possible, cure, cancer patients. The Mater has a special, collaborative approach to the treatment of cancer, promoting strong partnerships between scientists and doctors to ensure our patients are the first to benefit from new advances in treatment.
The Mater Medical Research Institute
The Mater Medical Research Institute is a world-class medical research institute conducting research that is aimed at improving health care.
Driven by a ‘bench to bedside’ philosophy, the MMRI's leading scientists work alongside doctors to turn basic scientific discovery into better treatment for patients.
The MMRI is helping to improve treatment for a range of illnesses and diseases including:
- Cancer including prostate cancer, leukaemia, lymphoma, and multiple myeloma
- Inflammatory bowel diseases such as Crohns disease and Ulcerative Colitis
- Gastrointestinal bacteria such as Helicobacter and Campylobacter
- Type 1 Diabetes
- Heart attack
- Stroke
- Complications of solid organ and bone marrow transplants
- Infectious diseases including Hepatitis C and HIV
Mater Prostate Cancer Research Centre
Every year around 11,000 Australian men are diagnosed with prostate cancer and more than 2,700 die of the disease.
The good news is that scientists at the Mater Prostate Cancer Research Centre (MPCRC) are giving new hope to prostate cancer sufferers.
The centre combines the research activities and clinical trials of Mater Medical Research Institute (MMRI) and the clinical activities of the Mater Hospitals’ relating to the treatment and management of prostate cancer.